Armistice Capital »

Scilex Holding shares owned by Armistice Capital

Quarter-by-quarter ownership of Scilex Holding (SCLX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Scilex Holding

Tip: Access up to 7 years of quarterly data

All positions including Scilex Holding held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scilex Holding by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $23M 12M 1.93

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Scilex Holding

Armistice Capital
State Street Corporation
BlackRock
BlackRock
Vanguard Group
Geode Capital Management
Northern Trust
Citadel Advisors
D. E. Shaw & Co
Rafferty Asset Management
Citigroup
Henderson Group
Jpmorgan Chase & Co
RA Capital Management
Heights Capital Management

View all funds holding Scilex Holding